Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copaxone in Acute Primary Angle Closure
NCT01936129Phase 3Unknown
- Sponsor
- Singapore Eye Research Institute
- Start
- Sep 2010
- Primary completion
- Oct 2013
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of glatiramer acetate in Acute Primary Angle Closure Glaucoma (APACG), sponsored by Singapore Eye Research Institute. Status: unknown.
02
Drugs
glatiramer acetate
03
Conditions
Acute Primary Angle Closure Glaucoma (APACG)
Beyond the preview
Go deeper on NCT01936129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01936129.